Fueled by positive early data, Genentech is in discussions with FDA regarding a potential sBLA submission for Avastin (bevacizumab) for renal cell cancer, the company announced
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.
Generative artificial intelligence tools, such as ChatGPT, have “democratized” AI, and contract research organizations are wholeheartedly embracing these tools, given their focus on efficiency, says Stephen Pyke, who chairs the AI committee at the Association of Clinical Research Organizations.
Japan gives world-first approval recommendations to two domestically originated drugs, for insomnia and glaucoma/ocular hypertension.
